Longitudinal change of cerebral amyloid and tau and its association with plasma biomarkers in preclinical Alzheimer's disease
Alfonso Fajardo, Yara Yakoub, Jonathan Gallego Rudolf, Jordana Remz, Jean‐Paul Soucy, Nicholas J. Ashton, Henrik Zetterberg, Kaj Blennow, John C.S. Breitner, Judes Poirier, Sylvia Villeneuve, PREVENT‐AD Research Group · 2025
Read Longitudinal change of cerebral amyloid and tau and its association with plasma biomarkers in preclinical Alzheimer's disease by Alfonso Fajardo, Yara Yakoub, Jonathan Gallego Rudolf, Jordana Remz, Jean‐Paul Soucy, Nicholas J. Ashton, Henrik Zetterberg, Kaj Blennow, John C.S. Breitner, Judes Poirier, Sylvia Villeneuve, PREVENT‐AD Research Group (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11715284.txt.
Description
Alfonso Fajardo leads a team, with the PREVENT-AD Research Group, in a 2025 study of brain amyloid and tau change in preclinical Alzheimer's disease. For care, these proteins are often cut to a plain yes or no, yet they build up for years before they cross that line.
The team tracked PET scans of amyloid and tau over time in people with no signs of poor thinking. They also read blood levels of the same markers and basic facts about each person. The goal was to link those blood and personal facts to how fast brain amyloid and tau grew each year.
Catalog record
| CREATOR | Alfonso Fajardo, Yara Yakoub, Jonathan Gallego Rudolf, Jordana Remz, Jean‐Paul Soucy, Nicholas J. Ashton, Henrik Zetterberg, Kaj Blennow, John C.S. Breitner, Judes Poirier, Sylvia Villeneuve, PREVENT‐AD Research Group |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 3 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |